» Articles » PMID: 14513203

Beta-amyloid Prevents Excitotoxicity Via Recruitment of Glial Glutamate Transporters

Overview
Specialty Pharmacology
Date 2003 Sep 27
PMID 14513203
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid beta-protein (Abeta), a putative pathogenic endotoxin involved in Alzheimer's disease, induces redistribution of glutamate transporters in astrocytes and promotes their pump activity. Because the transporters are assumed to protect neurons against excitotoxicity by removing extracellular glutamate, we hypothesized that Abeta alters the vulnerability of neurons to glutamate. Cerebrocortical neuron-astroglial co-cultures were exposed to glutamate, the concentration of which was selected so that only 20% of the neurons exhibited degeneration. When cultures were pre-treated with Abeta, exposure to the same "mild" glutamate concentration failed to damage neurons. The Abeta-induced protection was abolished by a glial glutamate transporter inhibitor. Thus, Abeta can alleviate excitotoxicity through glutamate transporter activity. The present results may challenge prevailing concepts that Abeta-induced neuron loss causes Alzheimer's dementia and also provide practical insights into neuro-glial interactions in glutamate toxicity.

Citing Articles

BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease.

Chami L, Checler F Mol Neurodegener. 2012; 7:52.

PMID: 23039869 PMC: 3507664. DOI: 10.1186/1750-1326-7-52.


Role of thiamine in Alzheimer's disease.

Luong K, Nguyen L Am J Alzheimers Dis Other Demen. 2012; 26(8):588-98.

PMID: 22218733 PMC: 10845378. DOI: 10.1177/1533317511432736.


Beta-amyloid 25-35 peptide reduces the expression of glutamine transporter SAT1 in cultured cortical neurons.

Buntup D, Skare O, Solbu T, Chaudhry F, Storm-Mathisen J, Thangnipon W Neurochem Res. 2007; 33(2):248-56.

PMID: 18058230 PMC: 2226019. DOI: 10.1007/s11064-007-9527-2.

References
1.
Abe K, Abe Y, Saito H . Evaluation of L-glutamate clearance capacity of cultured rat cortical astrocytes. Biol Pharm Bull. 2000; 23(2):204-7. DOI: 10.1248/bpb.23.204. View

2.
Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

3.
Stephan A, Laroche S, Davis S . Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci. 2001; 21(15):5703-14. PMC: 6762634. View

4.
Larson J, Lynch G, Games D, Seubert P . Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 1999; 840(1-2):23-35. DOI: 10.1016/s0006-8993(99)01698-4. View

5.
Davies C, Mann D, Sumpter P, YATES P . A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci. 1987; 78(2):151-64. DOI: 10.1016/0022-510x(87)90057-8. View